We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




Faulty Gene May Trigger Early Heart Disease

By Biotechdaily staff writers
Posted on 14 Aug 2002
A study into causes of premature coronary artery disease (CAD) has found that the presence of the R1141X mutation in the ABCC6 gene is associated with a sharply increased risk of premature CAD. More...
The study was published in the August 5, 2002, online edition of Circulation.

The R1141X mutation is the most frequent mutation found in the ABCC6 gene in patients suffering from pseudoxanthoma elasticum (PXE), a rare disorder of the connective tissue in the skin, retina, and artery walls. The mutation, which occurs in about one in 100,000 people can be inherited or occur spontaneously.

Examining nearly 1,500 Dutch people, investigators from the University of Amsterdam (NL; www.uva.nl) found that carriers of this mutation were 4.2 times more likely to have heart disease before age 50 than noncarriers.

"Our results seem to indicate that the R1141X mutation in the ABCC6 gene is not rare in the general population and contributes to an increased propensity toward premature heart disease, explained Dr. Mieke D. Trip, the report's lead author and an internist at the University of Amsterdam. "In addition, we could not find a relationship between this mutation and other major risk factors for heart disease, suggesting that this mutation is operating through a novel pathway to cause coronary heart disease.”

Dr. Trip says if the data are confirmed by other studies, they may lead to genetic screening of PXE families and a more aggressive approach toward the prevention of CAD.



Related Links:
University of Amsterdam

Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Automatic Hematology Analyzer
CF9600
HPV Test
Allplex HPV28 Detection
Platinum Member
Integrated Biochemical & Immunological System
Biolumi CX Solution X10+C10
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Alzheimer’s pathology can start 15 to 20 years before symptoms, and validated tools that reach patients earlier help pave the way for earlier detection. (Image Credit: Adobe Stock)

Alzheimer’s Blood Test Becomes First FDA-Cleared Option for Adults as Young as 40

C2N Diagnostics’ PrecivityAD2 blood test was cleared by the U.S. Food and Drug Administration (FDA) on August 20, 2026, for adults as young as 40 who are experiencing signs of cognitive impairment, according... Read more

Pathology

view channel
Image: Adrenal gland tumor stained with hematoxylin and eosin (top) and CYP11B2 (bottom) (Photo courtesy of Christofer Juhlin)

Simple Immunohistochemical Size Ratio Improves Classification of Primary Aldosteronism

Primary aldosteronism is a common but underdiagnosed cause of hypertension, in which excess aldosterone promotes salt retention and raises blood pressure. Identifying the dominant source of hormone overproduction... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.